网站二维码

网站地图页面

网站版权页面

Copyright:Yantai Zhenghai Bio-tech Co., Ltd.      鲁ICP备11012157号-1 

 

Company News
Media Coverage
Industry News

Information details

New Situation, New Cooperation and New Development - the Meeting of the National key R&D Program Led by ZH-BIO was Kicked off Su

[Abstract]:
OnOctober10,2016,the2016nationalkeyR&DprogramledbyZH-BIO-thekick-offmeetingoftheprojectof"R&DofRegenerativeandRepairBiologicalMaterialProductsforSpinalCordandBrainInjury"wassuccessfullyheldinYantai,Sh
On October 10, 2016, the 2016 national key R&D program led by ZH-BIO - the kick-off meeting of the project of "R&D of Regenerative and Repair Biological Material Products for Spinal Cord and Brain Injury" was successfully held in Yantai, Shandong. Zhang Sai, director of Brain Hospital of Chinese People's Armed Police Forces, Mr. Xu Weihua, secretary of the Party Committee of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Professor Dai Jianwu, director of Regenerative Medicine Research Center of the Institute of Genetics and Developmental Biology, Chinese Academy of Science and experts from 8 units participating in the project attended the meeting. Mr. Li Ruiqing, deputy director general of Yantai Science and Technology Bureau, Ms. Yu Ling, deputy director of Yantai Development Zone Administrative Committee, Mr. Cao Dongsheng, deputy director general of Yantai Science and Technology Bureau of the Development Zone, Mr. Mi Bohai, chairman of ZH-BIO, Mr. Zhang Wencai, general manager of ZH-BIO and Ms. Lu Meijiao, deputy general manager of ZH-BIO attended the meeting. 
Speech by Mr. Mi Bohai, chairman of ZH-BIO
At the meeting, Mr. Mi Bohai, chairman of ZH-BIO delivered a welcome speech and expressed his heartfelt thanks to the strong support from competent authorities at all levels and great help from colleagues in the industry. He said that ZH-BIO shouldered the mission of developing national brands and a road to innovation with constant pursuit of excellence in the past thirteen years. As the leading unit of the project, ZH-BIO will jointly enhance the cooperative development and innovation ability, effectively integrate industrial technology innovation resources and break through the key technology that constraints the development of the industry along with excellent research capacity in the industry to make new contributions to jointly enhancing the international influence of the research on bio-regenerative materials in China and leading the rapid development of the industry. 
Speech by Ms. Yu Ling, deputy director of Yantai Development Zone Administrative Committee
At the meeting, Ms. Yu Ling, deputy director of Yantai Development Zone Administrative Committee, introduced the development of science and technology innovation in Yantai Development Zone. She stressed that the bio-pharmaceutical industry was one of the three major strategic emerging industries in Yantai Development Zone with strong industrial base, complete professional categories and obvious cluster advantages. After years of development, a number of outstanding bio-pharmaceutical enterprises emerged and ZH-BIO was one of the typical representatives. The national key R&D program of ZH-BIO has been approved, which will further accelerate the pace of scientific and technological innovation of the bio-pharmaceutical industry in Yantai Development Zone and will make new contributions to the development of economic transformation and industrial upgrading of the whole region.
Speech by Mr. Xu Weihua, secretary of the Party Committee of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
Mr. Xu Weihua, secretary of the Party Committee of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, delivered an important speech. He expressed his warm congratulations on the approval of the project. He said that the development of enterprises required the long-term accumulation, vision of entrepreneurs and strong support of people from all walks of life. The implementation of the project requires each unit to adopt others' strong points while overcoming its weak points and jointly explore and create new models through cooperation with absolute sincerity. Simultaneously, relying on the advantages of the project, each unit should strengthen the basic researches, promote the transformation of results, aim at the forefront in the world and strive to tackle key problems to create the world's first-class or even leading results with great efforts and make greater contributions to realizing the goal of the "13th Five-Year Plan" of the country. 
Speech by Professor Zhang Sai, chief expert in the clinical research on the spinal cord and brain injury of ZH-BIO
At the meeting, Professor Zhang Sai, chief expert in the clinical research on the spinal cord and brain injury of ZH-BIO, provided profound interpretation of the overall situation of the project. He explained that repairing the central nervous system injury was a worldwide problem all the time. Although the central nervous system injury can activate endogenous neural stem cells, microenvironment of the injured parts will inhibit differentiation to neurons of neural stem cells and repair of neural regeneration. The implementation of the project can help reconstruct the microenvironment of neural regeneration and research and develop a series of bio-regenerative material products for repairing the central nervous system with completely independent intellectual property rights, which will greatly promote recovery of neural functions for patients with brain and spinal cord injury and will further lead the industrial and technological progress of global bio-regenerative materials with important economic and social benefits. Simultaneously, as a person responsible for the project, he stressed that in terms of each subject, its own positioning shall be accurately determined as soon as possible with clear management responsibilities to actively and orderly promote the implementation of the project. in addition, he said, attention should be paid to achieve the objectives of the tasks of the project on priority, focus on management and innovation of ways and methods and attach importance to the project approval as well as attach greater importance to process management and project acceptance. He hoped that ZH-BIO along with other 8 entities will try their best to complete this task led by ZH-BIO, which is the glory and responsibility. 
Director Zhang Sai, Secretary Xu Weihua, Professor Dai Jianwu, Deputy Director Yu Ling, Chairman Mi Bohai and General Manager Zhang Wencai started the kick-off ceremony together
At the meeting, people in charge of the topics reported respectively the objectives of topics, assignment of tasks, assessment indicators, schedule, promotion measures, etc. The members of the expert group addressed inquiries to the reports of the research group and made some suggestions. Experts said that the necessity of the project approval was strong, with obvious innovativeness and greatly significant R&D. They also put forward specific requirements of high technical requirements on research contents and big challenges, which needed to be implemented and promoted. 
Mr. Zhang Wencai, general manager of ZH-BIO, summarized the meeting
Mr. Zhang Wencai, general manager of ZH-BIO, summarized the meeting. He said that ZH-BIO would certainly do well in the national key R&D program, strive to become an enterprise that can set an example in the bio-regenerative material products in China, create the outstanding national brand and enhance the international influence of the bio-regenerative material products in China. Simultaneously, he wished the project of the national key R&D program - "R&D of Regenerative and Repair Biological Material Products for Spinal Cord and Brain Injury" a great success! 
Previous post:ZH-BIO Held the Tissue Repair Seminar of Otorhinolaryngology-head & Neck Surgery
Next post:[New Year's Annual Meeting] ZH-BIO Annual Meeting 2017 was Smoothly Held